Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Correvio Pharma Corp. CORV

Healthcare Drug Manufacturers - Major
Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial... see more

Bullboard (NDAQ:CORV)

View:
1 2 3 Next
Comment by slitheyon Apr 13, 2020 5:24pm

RE:RE:why it is very risky to invest?

This is nearly following William Hunter's playbook with angiotech some years ago: develop a drug product with decent sales, expand through acquisitions taking on debt at high interest that were ...more  
141
Discussion
Comment by bigkaganon Mar 05, 2020 4:10pm

RE:RE:RE:+50% today!

I wasn't far off, apparently Xydalba was mentioned on ABC News as used in the corona treatment according to people on Stocktwits 
146
Discussion
Comment by bigkaganon Mar 05, 2020 3:53pm

RE:RE:+50% today!

could it be anything to do with the Zevtera drug used against pneumonia? I bet some of these corona patients develop bacterial pneumonia also following the viral pneumonia
124
Discussion
Post by coolfooldumbguyon Feb 24, 2020 11:16am

still holding this stock

using dollar cost averaging for this one and it is going up today with markets crashing,so glta.
113
Post by shareswapperon Feb 13, 2020 11:13am

Is Correvio Getting Bought By Cipher?

On SEDAR Cipher has posted "Articles of Amalgamation" with Cardiome Corporation which I bleieve was Correvios former name?  Can someone help me here? https://sedar.com/CheckCode.do
148
Comment by bigkaganon Dec 30, 2019 11:42pm

RE:RE:Aww man this was supposed to be my early retirement 🤢

if China approves Brinavess we could go back to $2 easy IMHO, they are not as fussy as FDA which still bans the cyclamate although the whole world allows it
165
Discussion
Comment by bigkaganon Dec 28, 2019 6:27pm

RE:Aww man this was supposed to be my early retirement 🤢

there are still IPCI, MDNA, TLT and ONC, ha
127
Discussion
Post by ZackDoyle43on Dec 24, 2019 10:29pm

Something on CORV

ICYM l https://cutt.ly/srrijJl
142
Comment by bigkaganon Dec 23, 2019 12:16am

RE:RE:RE:RE:RE:RE:why it is very risky to invest?

may be there be good news tomorrow and Happy Holidays to everybody {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/watch?v=tt14DzZbB78|(fs)True|(loop)False|(autoplay ...more  
160
Discussion
Comment by bigkaganon Dec 17, 2019 10:36am

RE:RE:RE:RE:RE:why it is very risky to invest?

Consequently, on December 10, 2019, the FDA voted against approval of the NDA. On this news, Correvio shares fell 67% to close at $0.46 per share. The stock continues to decline. Read more at https ...more  
222
Discussion
Comment by bigkaganon Dec 16, 2019 2:55pm

RE:RE:RE:RE:why it is very risky to invest?

bought some more today to average down for the fraction of the price I paid when it was above $3, remember that it was in the $4's a year ago without any US Brinavess, let's go, hee 
129
Discussion
Comment by bigkaganon Dec 12, 2019 10:35pm

RE:RE:RE:why it is very risky to invest?

it's still too early to bury CORV because they'll make $30 mil, in revenue this year. Their problem has been too many expenses but now they're saying they''ll cut them in N.America ...more  
196
Discussion
Comment by mingzhuon Dec 12, 2019 9:48pm

RE:RE:why it is very risky to invest?

it does not mean much even FED approves Treyent because CORV has no right to sell in U.S. Only United tech has U.S right. CORV can only use the document to apply for approval in EU. It will take long ...more  
155
Discussion
Comment by bigkaganon Dec 12, 2019 5:36pm

RE:lawsuits start now

there can be no lawsuit until FDA has officially rejected the re-application on Dec.24(Happy Xmas) and it's still up in the air what will be decided
113
Discussion
Post by mingzhuon Dec 12, 2019 4:50pm

lawsuits start now

https://ca.finance.yahoo.com/news/important-investor-alert-schall-law-214200544.html
171
Discussion
1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities